APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Logistic

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

Selected research

Market Outlook & Growth Opportunities

Global Biopharmaceutical Logistic Market Outlook and Growth Opportunities 2026

25 December 2025202 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Logistic Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Logistic Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Logistic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Logistic Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Logistic Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

Market competition is intense. Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken) and DB Schenker, etc. are the leaders of the industry, and they hold key technologies, with high-end customers; have been formed in the monopoly position in the industry. The top six players got about 20% market shares. North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

This report provides an overview of the global Biopharmaceutical Logistic market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Biopharmaceutical Logistic and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biopharmaceutical Logistic revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biopharmaceutical Logistic market.

Biopharmaceutical Logistic Segment by Company

Deutsche Post DHL

Kuehne + Nagel

FedEx

AmerisourceBergen

UPS (Marken)

DB Schenker

XPO Logistics

Panalpina

Nippon Express

GEODIS

VersaCold

Agility

DSV

Sinotrans

Kerry Logistics

SF Express

CEVA

CH Robinson

Air Canada Cargo

Biopharmaceutical Logistic Segment by Type

Cold Chain Logistics

Non-cold Chain Logistics

Biopharmaceutical Logistic Segment by Application

Ground Shipping

Sea Shipping

Air Shipping

Biopharmaceutical Logistic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biopharmaceutical Logistic status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biopharmaceutical Logistic key companies, revenue, market share, and recent developments.

3. To split the Biopharmaceutical Logistic breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biopharmaceutical Logistic market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biopharmaceutical Logistic significant trends, drivers, influence factors in global and regions.

6. To analyze Biopharmaceutical Logistic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Logistic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Logistic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Logistic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceutical Logistic industry.

Chapter 3: Detailed analysis of Biopharmaceutical Logistic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biopharmaceutical Logistic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biopharmaceutical Logistic in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biopharmaceutical Logistic Industry Trends Table 2. Biopharmaceutical Logistic Industry Drivers Table 3. Biopharmaceutical Logistic Industry Opportunities and Challenges Table 4. Biopharmaceutical Logistic Industry Restraints Table 5. Global Biopharmaceutical Logistic Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biopharmaceutical Logistic Revenue Share by Company (2021-2026) Table 7. Global Biopharmaceutical Logistic Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biopharmaceutical Logistic Key Company Manufacturing Base & Headquarters Table 9. Global Biopharmaceutical Logistic Company, Product Type & Application Table 10. Global Biopharmaceutical Logistic Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biopharmaceutical Logistic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cold Chain Logistics Table 15. Significant Companies of Non-cold Chain Logistics Table 16. Global Biopharmaceutical Logistic Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biopharmaceutical Logistic Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biopharmaceutical Logistic Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biopharmaceutical Logistic Sales Value Share by Type (2021-2026) Table 20. Global Biopharmaceutical Logistic Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Ground Shipping Table 22. Significant Companies of Sea Shipping Table 23. Significant Companies of Air Shipping Table 24. Global Biopharmaceutical Logistic Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biopharmaceutical Logistic Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Biopharmaceutical Logistic Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Biopharmaceutical Logistic Sales Value Share by Application (2021-2026) Table 28. Global Biopharmaceutical Logistic Sales Value Share by Application (2027-2032) Table 29. Global Biopharmaceutical Logistic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biopharmaceutical Logistic Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Biopharmaceutical Logistic Sales Value Share by Region (2021-2026) Table 32. Global Biopharmaceutical Logistic Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Biopharmaceutical Logistic Sales Value Share by Region (2027-2032) Table 34. Global Biopharmaceutical Logistic Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biopharmaceutical Logistic Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Biopharmaceutical Logistic Sales Value Market Share by Country (2021-2026) Table 37. Global Biopharmaceutical Logistic Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Biopharmaceutical Logistic Sales Value Market Share by Country (2027-2032) Table 39. Deutsche Post DHL Company Information Table 40. Deutsche Post DHL Business Overview Table 41. Deutsche Post DHL Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio Table 43. Deutsche Post DHL Recent Development Table 44. Kuehne + Nagel Company Information Table 45. Kuehne + Nagel Business Overview Table 46. Kuehne + Nagel Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio Table 48. Kuehne + Nagel Recent Development Table 49. FedEx Company Information Table 50. FedEx Business Overview Table 51. FedEx Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. FedEx Biopharmaceutical Logistic Product Portfolio Table 53. FedEx Recent Development Table 54. AmerisourceBergen Company Information Table 55. AmerisourceBergen Business Overview Table 56. AmerisourceBergen Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. AmerisourceBergen Biopharmaceutical Logistic Product Portfolio Table 58. AmerisourceBergen Recent Development Table 59. UPS (Marken) Company Information Table 60. UPS (Marken) Business Overview Table 61. UPS (Marken) Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. UPS (Marken) Biopharmaceutical Logistic Product Portfolio Table 63. UPS (Marken) Recent Development Table 64. DB Schenker Company Information Table 65. DB Schenker Business Overview Table 66. DB Schenker Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. DB Schenker Biopharmaceutical Logistic Product Portfolio Table 68. DB Schenker Recent Development Table 69. XPO Logistics Company Information Table 70. XPO Logistics Business Overview Table 71. XPO Logistics Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. XPO Logistics Biopharmaceutical Logistic Product Portfolio Table 73. XPO Logistics Recent Development Table 74. Panalpina Company Information Table 75. Panalpina Business Overview Table 76. Panalpina Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Panalpina Biopharmaceutical Logistic Product Portfolio Table 78. Panalpina Recent Development Table 79. Nippon Express Company Information Table 80. Nippon Express Business Overview Table 81. Nippon Express Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Nippon Express Biopharmaceutical Logistic Product Portfolio Table 83. Nippon Express Recent Development Table 84. GEODIS Company Information Table 85. GEODIS Business Overview Table 86. GEODIS Biopharmaceutical Logistic Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. GEODIS Biopharmaceutical Logistic Product Portfolio Table 88. GEODIS Recent Development Table 89. VersaCold Company Information Table 90. VersaCold Business Overview Table 91. VersaCold Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. VersaCold Biopharmaceutical Logistic Product Portfolio Table 93. VersaCold Recent Development Table 94. Agility Company Information Table 95. Agility Business Overview Table 96. Agility Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Agility Biopharmaceutical Logistic Product Portfolio Table 98. Agility Recent Development Table 99. DSV Company Information Table 100. DSV Business Overview Table 101. DSV Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. DSV Biopharmaceutical Logistic Product Portfolio Table 103. DSV Recent Development Table 104. Sinotrans Company Information Table 105. Sinotrans Business Overview Table 106. Sinotrans Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Sinotrans Biopharmaceutical Logistic Product Portfolio Table 108. Sinotrans Recent Development Table 109. Kerry Logistics Company Information Table 110. Kerry Logistics Business Overview Table 111. Kerry Logistics Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Kerry Logistics Biopharmaceutical Logistic Product Portfolio Table 113. Kerry Logistics Recent Development Table 114. SF Express Company Information Table 115. SF Express Business Overview Table 116. SF Express Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. SF Express Biopharmaceutical Logistic Product Portfolio Table 118. SF Express Recent Development Table 119. CEVA Company Information Table 120. CEVA Business Overview Table 121. CEVA Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. CEVA Biopharmaceutical Logistic Product Portfolio Table 123. CEVA Recent Development Table 124. CH Robinson Company Information Table 125. CH Robinson Business Overview Table 126. CH Robinson Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. CH Robinson Biopharmaceutical Logistic Product Portfolio Table 128. CH Robinson Recent Development Table 129. Air Canada Cargo Company Information Table 130. Air Canada Cargo Business Overview Table 131. Air Canada Cargo Biopharmaceutical Logistic Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 132. Air Canada Cargo Biopharmaceutical Logistic Product Portfolio Table 133. Air Canada Cargo Recent Development Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Biopharmaceutical Logistic Product Image Figure 2. Global Biopharmaceutical Logistic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical Logistic Market Size (2021-2032) & (US$ Million) Figure 4. Global Biopharmaceutical Logistic Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cold Chain Logistics Image Figure 8. Non-cold Chain Logistics Image Figure 9. Global Biopharmaceutical Logistic Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biopharmaceutical Logistic Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biopharmaceutical Logistic Sales Value Share by Type (2021-2032) Figure 12. Ground Shipping Image Figure 13. Sea Shipping Image Figure 14. Air Shipping Image Figure 15. Global Biopharmaceutical Logistic Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biopharmaceutical Logistic Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Biopharmaceutical Logistic Sales Value Share by Application (2021-2032) Figure 18. Global Biopharmaceutical Logistic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Biopharmaceutical Logistic Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Biopharmaceutical Logistic Sales Value (2021-2032) & (US$ Million) Figure 21. North America Biopharmaceutical Logistic Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Biopharmaceutical Logistic Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Biopharmaceutical Logistic Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Biopharmaceutical Logistic Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Biopharmaceutical Logistic Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Biopharmaceutical Logistic Sales Value (2021-2032) & (US$ Million) Figure 27. South America Biopharmaceutical Logistic Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Biopharmaceutical Logistic Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Biopharmaceutical Logistic Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cold Chain Logistics
  • Non-cold Chain Logistics
Applications
  • Ground Shipping
  • Sea Shipping
  • Air Shipping
Companies covered
  • Deutsche Post DHL
  • Kuehne + Nagel
  • FedEx
  • AmerisourceBergen
  • UPS (Marken)
  • DB Schenker
  • XPO Logistics
  • Panalpina
  • Nippon Express
  • GEODIS
  • VersaCold
  • Agility
  • DSV
  • Sinotrans
  • Kerry Logistics
  • SF Express
  • CEVA
  • CH Robinson
  • Air Canada Cargo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biopharmaceutical Logistic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biopharmaceutical Logistic Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biopharmaceutical Logistic Market Dynamics
  1. 2.1 Biopharmaceutical Logistic Industry Trends
  2. 2.2 Biopharmaceutical Logistic Industry Drivers
  3. 2.3 Biopharmaceutical Logistic Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical Logistic Industry Restraints
3 Biopharmaceutical Logistic Market by Company
  1. 3.1 Global Biopharmaceutical Logistic Company Revenue Ranking in 2025
  2. 3.2 Global Biopharmaceutical Logistic Revenue by Company (2021-2026)
  3. 3.3 Global Biopharmaceutical Logistic Company Ranking (2024-2026)
  4. 3.4 Global Biopharmaceutical Logistic Company Manufacturing Base and Headquarters
  5. 3.5 Global Biopharmaceutical Logistic Company Product Type and Application
  6. 3.6 Global Biopharmaceutical Logistic Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biopharmaceutical Logistic Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biopharmaceutical Logistic Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biopharmaceutical Logistic Market by Type
  1. 4.1 Biopharmaceutical Logistic Type Introduction
  2. 4.1.1 Cold Chain Logistics
  3. 4.1.2 Non-cold Chain Logistics
  4. 4.2 Global Biopharmaceutical Logistic Sales Value by Type
  5. 4.2.1 Global Biopharmaceutical Logistic Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biopharmaceutical Logistic Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biopharmaceutical Logistic Sales Value Share by Type (2021-2032)
5 Biopharmaceutical Logistic Market by Application
  1. 5.1 Biopharmaceutical Logistic Application Introduction
  2. 5.1.1 Ground Shipping
  3. 5.1.2 Sea Shipping
  4. 5.1.3 Air Shipping
  5. 5.2 Global Biopharmaceutical Logistic Sales Value by Application
  6. 5.2.1 Global Biopharmaceutical Logistic Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biopharmaceutical Logistic Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biopharmaceutical Logistic Sales Value Share by Application (2021-2032)
6 Biopharmaceutical Logistic Regional Value Analysis
  1. 6.1 Global Biopharmaceutical Logistic Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biopharmaceutical Logistic Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biopharmaceutical Logistic Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biopharmaceutical Logistic Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biopharmaceutical Logistic Sales Value (2021-2032)
  7. 6.3.2 North America Biopharmaceutical Logistic Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biopharmaceutical Logistic Sales Value (2021-2032)
  10. 6.4.2 Europe Biopharmaceutical Logistic Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biopharmaceutical Logistic Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biopharmaceutical Logistic Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biopharmaceutical Logistic Sales Value (2021-2032)
  16. 6.6.2 South America Biopharmaceutical Logistic Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biopharmaceutical Logistic Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biopharmaceutical Logistic Sales Value Share by Country, 2025 VS 2032
7 Biopharmaceutical Logistic Country-level Value Analysis
  1. 7.1 Global Biopharmaceutical Logistic Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biopharmaceutical Logistic Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biopharmaceutical Logistic Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biopharmaceutical Logistic Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biopharmaceutical Logistic Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biopharmaceutical Logistic Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biopharmaceutical Logistic Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Deutsche Post DHL
  2. 8.1.1 Deutsche Post DHL Company Information
  3. 8.1.2 Deutsche Post DHL Business Overview
  4. 8.1.3 Deutsche Post DHL Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio
  6. 8.1.5 Deutsche Post DHL Recent Developments
  7. 8.2 Kuehne + Nagel
  8. 8.2.1 Kuehne + Nagel Company Information
  9. 8.2.2 Kuehne + Nagel Business Overview
  10. 8.2.3 Kuehne + Nagel Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio
  12. 8.2.5 Kuehne + Nagel Recent Developments
  13. 8.3 FedEx
  14. 8.3.1 FedEx Company Information
  15. 8.3.2 FedEx Business Overview
  16. 8.3.3 FedEx Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  17. 8.3.4 FedEx Biopharmaceutical Logistic Product Portfolio
  18. 8.3.5 FedEx Recent Developments
  19. 8.4 AmerisourceBergen
  20. 8.4.1 AmerisourceBergen Company Information
  21. 8.4.2 AmerisourceBergen Business Overview
  22. 8.4.3 AmerisourceBergen Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AmerisourceBergen Biopharmaceutical Logistic Product Portfolio
  24. 8.4.5 AmerisourceBergen Recent Developments
  25. 8.5 UPS (Marken)
  26. 8.5.1 UPS (Marken) Company Information
  27. 8.5.2 UPS (Marken) Business Overview
  28. 8.5.3 UPS (Marken) Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  29. 8.5.4 UPS (Marken) Biopharmaceutical Logistic Product Portfolio
  30. 8.5.5 UPS (Marken) Recent Developments
  31. 8.6 DB Schenker
  32. 8.6.1 DB Schenker Company Information
  33. 8.6.2 DB Schenker Business Overview
  34. 8.6.3 DB Schenker Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DB Schenker Biopharmaceutical Logistic Product Portfolio
  36. 8.6.5 DB Schenker Recent Developments
  37. 8.7 XPO Logistics
  38. 8.7.1 XPO Logistics Company Information
  39. 8.7.2 XPO Logistics Business Overview
  40. 8.7.3 XPO Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  41. 8.7.4 XPO Logistics Biopharmaceutical Logistic Product Portfolio
  42. 8.7.5 XPO Logistics Recent Developments
  43. 8.8 Panalpina
  44. 8.8.1 Panalpina Company Information
  45. 8.8.2 Panalpina Business Overview
  46. 8.8.3 Panalpina Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Panalpina Biopharmaceutical Logistic Product Portfolio
  48. 8.8.5 Panalpina Recent Developments
  49. 8.9 Nippon Express
  50. 8.9.1 Nippon Express Company Information
  51. 8.9.2 Nippon Express Business Overview
  52. 8.9.3 Nippon Express Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nippon Express Biopharmaceutical Logistic Product Portfolio
  54. 8.9.5 Nippon Express Recent Developments
  55. 8.10 GEODIS
  56. 8.10.1 GEODIS Company Information
  57. 8.10.2 GEODIS Business Overview
  58. 8.10.3 GEODIS Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GEODIS Biopharmaceutical Logistic Product Portfolio
  60. 8.10.5 GEODIS Recent Developments
  61. 8.11 VersaCold
  62. 8.11.1 VersaCold Company Information
  63. 8.11.2 VersaCold Business Overview
  64. 8.11.3 VersaCold Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  65. 8.11.4 VersaCold Biopharmaceutical Logistic Product Portfolio
  66. 8.11.5 VersaCold Recent Developments
  67. 8.12 Agility
  68. 8.12.1 Agility Company Information
  69. 8.12.2 Agility Business Overview
  70. 8.12.3 Agility Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Agility Biopharmaceutical Logistic Product Portfolio
  72. 8.12.5 Agility Recent Developments
  73. 8.13 DSV
  74. 8.13.1 DSV Company Information
  75. 8.13.2 DSV Business Overview
  76. 8.13.3 DSV Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DSV Biopharmaceutical Logistic Product Portfolio
  78. 8.13.5 DSV Recent Developments
  79. 8.14 Sinotrans
  80. 8.14.1 Sinotrans Company Information
  81. 8.14.2 Sinotrans Business Overview
  82. 8.14.3 Sinotrans Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sinotrans Biopharmaceutical Logistic Product Portfolio
  84. 8.14.5 Sinotrans Recent Developments
  85. 8.15 Kerry Logistics
  86. 8.15.1 Kerry Logistics Company Information
  87. 8.15.2 Kerry Logistics Business Overview
  88. 8.15.3 Kerry Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Kerry Logistics Biopharmaceutical Logistic Product Portfolio
  90. 8.15.5 Kerry Logistics Recent Developments
  91. 8.16 SF Express
  92. 8.16.1 SF Express Company Information
  93. 8.16.2 SF Express Business Overview
  94. 8.16.3 SF Express Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  95. 8.16.4 SF Express Biopharmaceutical Logistic Product Portfolio
  96. 8.16.5 SF Express Recent Developments
  97. 8.17 CEVA
  98. 8.17.1 CEVA Company Information
  99. 8.17.2 CEVA Business Overview
  100. 8.17.3 CEVA Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  101. 8.17.4 CEVA Biopharmaceutical Logistic Product Portfolio
  102. 8.17.5 CEVA Recent Developments
  103. 8.18 CH Robinson
  104. 8.18.1 CH Robinson Company Information
  105. 8.18.2 CH Robinson Business Overview
  106. 8.18.3 CH Robinson Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CH Robinson Biopharmaceutical Logistic Product Portfolio
  108. 8.18.5 CH Robinson Recent Developments
  109. 8.19 Air Canada Cargo
  110. 8.19.1 Air Canada Cargo Company Information
  111. 8.19.2 Air Canada Cargo Business Overview
  112. 8.19.3 Air Canada Cargo Biopharmaceutical Logistic Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Air Canada Cargo Biopharmaceutical Logistic Product Portfolio
  114. 8.19.5 Air Canada Cargo Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst